Login

Log In to SINEORA
Login with your social media account
or
Use your corporate e-mail address
New to SINEORA?
Find the best technology startups for your innovation or join our startup program. Create an account

register

Sign Up: Create your company account

By sign up you get the following benefits:

  • Select best local partner to continuously enrich our pipeline
  • Pre-screening relevant ones
  • Pre-screening the startups in our focused domain, namely AI, Industrial IoT, B2B software, Robotics and Blockchain
  • Startups Assessment Report (360-degree view with our originally developed methodology)
  • Deep understanding of corporates’ digital transformation challenges and constraints
  • Focusing on synergized scenario
  • Fine tune process empowered by our algorithm (per initiative)

Select the better description for your innovation company

If you already have an account,

corporate form

startup form

Enterome

Enterome

Privately owned personalized medicine company

59 employees
Launch date : 2011
Date Investor Amount
Mar 2012 Seventure PartnersLundbeckfonden Ventures SERIES A
€5m
May 2014 Seventure PartnersOmnes Venture CapitalLundbeckfonden Ventures SERIES B
€10m
Apr 2016 Seventure PartnersLundbeckfonden VenturesNestlé Health Science SERIES C
€14.5m
Jan 2018* Seventure PartnersOmnes Venture CapitalLundbeckfonden VenturesPrincipia SGRBristol-Myers SquibbNestlé Health ScienceHealth for Life Capital SERIES D
$38.5m
Jan 2018 European Investment Bank DEBT
€40m
Jun 2020 Seventure PartnersOmnes Venture CapitalPrincipia SGRNestlé Health ScienceTakedaHealth for Life CapitalSymBiosis SERIES E
€46.3m
Investor Amount
Seventure Partners SERIES E, SERIES D, SERIES C, SERIES B, SERIES A
Lundbeckfonden Ventures SERIES D, SERIES C, SERIES B, SERIES A
Omnes Venture Capital SERIES E, SERIES D, SERIES B
Health for Life Capital SERIES E, SERIES D
Nestlé Health Science SERIES E, SERIES D, SERIES C
Principia SGR SERIES E, SERIES D
Bristol-Myers Squibb SERIES D
European Investment Bank DEBT
SymBiosis SERIES E
Takeda SERIES E

RECENT NEWS

INTERACT WITH THIS STARTUP